Diagnostic Utility of SGLT2 Inhibitors to Facilitate Myocardial Glucose Suppression During Evaluation of Myocardial Inflammation

JACC Cardiovasc Imaging. 2024 Jul;17(7):827-829. doi: 10.1016/j.jcmg.2024.02.011. Epub 2024 Apr 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Biomarkers / blood
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocarditis / diagnostic imaging
  • Myocarditis / drug therapy
  • Myocardium* / metabolism
  • Myocardium* / pathology
  • Predictive Value of Tests
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
  • Treatment Outcome

Substances

  • Biomarkers
  • Blood Glucose
  • SLC5A2 protein, human
  • Sodium-Glucose Transporter 2 Inhibitors